| G02AD |
G02AD Prostaglandins |
| G02AD01 |
G02AD01 Dinoprost |
| G02AD02 |
G02AD02 Dinoprostone |
| G02AD03 |
G02AD03 Gemeprost |
| G02AD04 |
G02AD04 Carboprost |
| G02AD05 |
G02AD05 Sulprostone |
| G02AD06 |
G02AD06 Misoprostol |
| G02AX |
G02AX Other uterotonics |
| G02B |
G02B Contraceptives for topical use |
| G02BA |
G02BA Intrauterine contraceptives |
| G02BA01 |
G02BA01 Plastic IUD |
| G02BA02 |
G02BA02 Plastic IUD with copper |
| G02BA03 |
G02BA03 Plastic IUD with progestogen |
| G02BB |
G02BB Intravaginal contraceptives |
| G02BB01 |
G02BB01 Vaginal ring with progestogen and estrogen |
| G02BB02 |
G02BB02 vaginal ring with progestogen |
| G02C |
G02C Other gynecologicals |
| G02CA |
G02CA Sympathomimetics, labour repressants |
| G02CA01 |
G02CA01 Ritodrine |
| G02CA02 |
G02CA02 Buphenine |
| G02CA03 |
G02CA03 Fenoterol |
| G02CB |
G02CB Prolactine inhibitors |
| G02CB01 |
G02CB01 Bromocriptine |
| G02CB02 |
G02CB02 Lisuride |
| G02CB03 |
G02CB03 Cabergoline |
| G02CB04 |
G02CB04 Quinagolide |
| G02CB05 |
G02CB05 Metergoline |
| G02CB06 |
G02CB06 Terguride |
| G02CC |
G02CC Anti-inflammatory products for vaginal administration |
| G02CC01 |
G02CC01 ibuprofen |